Shanghai Yizhong Pharmaceutical Co., Ltd. (SHA:688091)

SHA:688091 Revenue

Shanghai Yizhong Pharmaceutical had revenue of 79.16M CNY in the quarter ending March 31, 2026, with 11.44% growth. This brings the company's revenue in the last twelve months to 325.20M, up 84.92% year-over-year. In the year 2025, Shanghai Yizhong Pharmaceutical had annual revenue of 317.08M with 82.72% growth.

• Revenue (ttm): 325.20M
• Revenue Growth: +84.92%
• P/S Ratio: 33.67
• Revenue / Employee: 867.21K
• Employees: 415
• Market Cap: 10.95B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	317.08M	143.54M	82.72%
Dec 31, 2024	173.53M	-186.72M	-51.83%
Dec 31, 2023	360.25M	124.30M	52.68%
Dec 31, 2022	235.96M	231.88M	5,686.75%
Dec 31, 2021	4.08M	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 29, 2026

Data Sources Report a data error